Search

Search Constraints

You searched for: Author/Creator Galadanci, Aisha

Search Results

1. Hydroxyurea for primary stroke prevention in children with sickle cell anaemia in Nigeria (SPRING): a double-blind, multicentre, randomised, phase 3 trial. Issue 1 (January 2022)

2. Moderate fixed‐dose hydroxyurea for primary prevention of strokes in Nigerian children with sickle cell disease: Final results of the SPIN trial. Issue 9 (10th July 2020)

3. Primary prevention of stroke in children with sickle cell anemia in sub-Saharan Africa: rationale and design of phase III randomized clinical trial. (24th November 2020)